{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:12:18Z","timestamp":1791843138746,"version":"4.3.4"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>As progress towards malaria elimination continues, the challenge posed by the parasite species <jats:italic>Plasmodium vivax<\/jats:italic> has become more evident. In many regions co-endemic for <jats:italic>P. vivax<\/jats:italic> and <jats:italic>Plasmodium falciparum<\/jats:italic>, as transmission has declined the proportion of cases due to <jats:italic>P. vivax<\/jats:italic> has increased. Novel tools that directly target <jats:italic>P. vivax<\/jats:italic> are thus warranted for accelerated elimination. There is currently no advanced vaccine for <jats:italic>P. vivax<\/jats:italic> and only a limited number of potential candidates in the pipeline. In this study we aimed to identify promising <jats:italic>P. vivax<\/jats:italic> proteins that could be used as part of a subunit vaccination approach. We screened 342\u00a0P<jats:italic>. vivax<\/jats:italic> protein constructs for their ability to induce IgG antibody responses associated with protection from clinical disease in a cohort of children from Papua New Guinea. This approach has previously been used to successfully identify novel candidates. We were able to confirm previous results from our laboratory identifying the proteins reticulocyte binding protein 2b and StAR-related lipid transfer protein, as well as at least four novel candidates with similar levels of predicted protective efficacy. Assessment of these <jats:italic>P. vivax<\/jats:italic> proteins in further studies to confirm their potential and identify functional mechanisms of protection against clinical disease are warranted.<\/jats:p>","DOI":"10.3389\/fcimb.2023.1076150","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:22:01Z","timestamp":1674627721000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of novel Plasmodium vivax proteins associated with protection against clinical malaria"],"prefix":"10.3389","volume":"13","author":[{"given":"Ramin","family":"Mazhari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eizo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhea J.","family":"Longley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Ruybal-Pesantez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard N.","family":"Kanoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Kiniboro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Siba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13071-018-2787-7","article-title":"High proportions of asymptomatic and submicroscopic plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon","volume":"11","author":"Almeida","year":"2018","journal-title":"Parasit Vectors"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12936-022-04085-x","article-title":"Comparison of total immunoglobulin G antibody responses to different protein fragments of plasmodium vivax reticulocyte binding protein 2b","volume":"21","author":"Bourke","year":"2022","journal-title":"Malar J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"16290","DOI":"10.1073\/pnas.0807404105","article-title":"The transcriptome of plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites","volume":"105","author":"Bozdech","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nature07327","article-title":"Comparative genomics of the neglected human malaria parasite plasmodium vivax","volume":"455","author":"Carlton","year":"2008","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12936-019-2826-7","article-title":"Clinical expression and antigenic profiles of a plasmodium vivax vaccine candidate: merozoite surface protein 7 (PvMSP-7)","volume":"18","author":"Cheng","year":"2019","journal-title":"Malar J."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00586","article-title":"Novel approaches to identify protective malaria vaccine candidates","volume":"5","author":"Chia","year":"2014","journal-title":"Front. Microbiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/192733a0","article-title":"Gamma-globulin and acquired immunity to human malaria","volume":"192","author":"Cohen","year":"1961","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.chom.2018.06.008","article-title":"Malaria vaccines: Recent advances and new horizons","volume":"24","author":"Draper","year":"2018","journal-title":"Cell Host Microbe"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.1074\/mcp.M113.036632","article-title":"Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria","volume":"13","author":"Finney","year":"2014","journal-title":"Mol. Cell Proteomics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005014","article-title":"Plasmodium vivax reticulocyte binding proteins are key targets of naturally acquired immunity in young Papua new guinean children","volume":"10","author":"Franca","year":"2016","journal-title":"PloS Negl. Trop. Dis."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.28673","article-title":"Identification of highly-protective combinations of plasmodium vivax recombinant proteins for vaccine development","volume":"6","author":"Franca","year":"2017","journal-title":"Elife"},{"key":"B12","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1126\/science.aan1078","article-title":"Transferrin receptor 1 is a reticulocyte-specific receptor for plasmodium vivax","volume":"359","author":"Gruszczyk","year":"2018","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/1475-2875-9-254","article-title":"A large proportion of asymptomatic plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of temotu province, Solomon islands: challenges for malaria diagnostics in an elimination setting","volume":"9","author":"Harris","year":"2010","journal-title":"Malar J."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007596","article-title":"Antibodies to plasmodium vivax reticulocyte binding protein 2b are associated with protection against p. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand","volume":"13","author":"He","year":"2019","journal-title":"PloS Negl. Trop. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"102224","DOI":"10.1016\/j.parint.2020.102224","article-title":"Leveraging the wheat germ cell-free protein synthesis system to accelerate malaria vaccine development","volume":"80","author":"Kanoi","year":"2021","journal-title":"Parasitol. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.vaccine.2017.01.001","article-title":"Antibody profiles to wheat germ cell-free system synthesized plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda","volume":"35","author":"Kanoi","year":"2017","journal-title":"Vaccine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002403","article-title":"A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children","volume":"7","author":"Koepfli","year":"2013","journal-title":"PloS Negl. Trop. Dis."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009047","article-title":"Differential patterns of infection and disease with p. falciparum and p. vivax in young Papua new guinean children","volume":"5","author":"Lin","year":"2010","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12936-017-1826-8","article-title":"Asymptomatic plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand","volume":"16","author":"Longley","year":"2017","journal-title":"Malar J."},{"key":"B20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1128\/CVI.00501-15","article-title":"Acquisition and longevity of antibodies to plasmodium vivax preerythrocytic antigens in Western Thailand","volume":"23","author":"Longley","year":"2016","journal-title":"Clin. Vaccine Immunol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1017\/S0031182015000670","article-title":"Insights into the naturally acquired immune response to plasmodium vivax malaria","volume":"143","author":"Longley","year":"2016","journal-title":"Parasitology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41591-020-0841-4","article-title":"Development and validation of serological markers for detecting recent plasmodium vivax infection","volume":"26","author":"Longley","year":"2020","journal-title":"Nat. Med."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005888","article-title":"Naturally acquired antibody responses to more than 300 plasmodium vivax proteins in three geographic regions","volume":"11","author":"Longley","year":"2017","journal-title":"PloS Negl. Trop. Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1186\/s13071-017-2407-y","article-title":"Very high carriage of gametocytes in asymptomatic low-density plasmodium falciparum and p. vivax infections in western Thailand","volume":"10","author":"Nguitragool","year":"2017","journal-title":"Parasit Vectors"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1080\/14760584.2021.1981864","article-title":"Multi-functional antibody profiling for malaria vaccine development and evaluation","volume":"20","author":"Opi","year":"2021","journal-title":"Expert Rev. Vaccines"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0273106","article-title":"Plasmodium falciparum serology: A comparison of two protein production methods for analysis of antibody responses by protein microarray","volume":"17","author":"Oulton","year":"2022","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","article-title":"Plasmodium vivax in the era of the shrinking p. falciparum map","volume":"36","author":"Price","year":"2020","journal-title":"Trends Parasitol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"102411","DOI":"10.1016\/j.parint.2021.102411","article-title":"Plasmodium vivax pre-erythrocytic vaccines","volume":"84","author":"Reyes-Sandoval","year":"2021","journal-title":"Parasitol. Int."},{"key":"B29","doi-asserted-by":"publisher","first-page":"12183","DOI":"10.1038\/s41598-018-30713-1","article-title":"Unraveling the plasmodium vivax sporozoite transcriptional journey from mosquito vector to human host","volume":"8","author":"Roth","year":"2018","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4269\/ajtmh.1991.45.297","article-title":"Parasitologic and clinical human response to immunoglobulin administration in falciparum malaria","volume":"45","author":"Sabchareon","year":"1991","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"B31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12936-018-2476-1","article-title":"Prevalence of asymptomatic plasmodium infections with sub-microscopic parasite densities in the northwestern border of Thailand: a potential threat to malaria elimination","volume":"17","author":"Sattabongkot","year":"2018","journal-title":"Malar J."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002498","article-title":"Naturally acquired immune responses to p. vivax merozoite surface protein 3\u03b1 and merozoite surface protein 9 are associated with reduced risk of p. vivax malaria in young Papua new guinean children","volume":"7","author":"Stanisic","year":"2013","journal-title":"PloS Negl. Trop. Dis."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003758","article-title":"High rates of asymptomatic, Sub-microscopic plasmodium vivax infection and disappearing plasmodium falciparum malaria in an area of low transmission in Solomon islands","volume":"9","author":"Waltmann","year":"2015","journal-title":"PloS Negl. Trop. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"102592","DOI":"10.1016\/j.parint.2022.102592","article-title":"Potential role of vaccines in elimination of plasmodium vivax","volume":"90","author":"White","year":"2022","journal-title":"Parasitol. Int."},{"key":"B35","unstructured":"GenevaWHO recommends groundbreaking malaria vaccine for children at risk2021"},{"key":"B36","volume-title":"World malaria report","year":"2021"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000770","article-title":"Long-lived antibody and b cell memory responses to the human malaria parasites, plasmodium falciparum and plasmodium vivax","volume":"6","author":"Wipasa","year":"2010","journal-title":"PloS Pathog."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1076150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T06:22:06Z","timestamp":1674627726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1076150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2023.1076150"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1076150","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"article-number":"1076150"}}